18th Annual Conference On Fraud And Abuse 2018 | American Conference Institute | 5 March 2018 | Omni Parker House Boston, 60 School St, Boston, MA 02108, USA

In the face of increased scrutiny of medical device companies, continued enforcement activities, and DOJ’s shifting of focus to smaller life sciences companies, ACI’s 18th fraud and abuse conference will once again provide a forum for legal and compliance professionals to engage with enforcers and network with peers.

Topics to keep in mind:

• Our 3-hour long detailed session on Strategies for Building an Effective Compliance Program for Small and Mid-Size Pharma and Device Companies, will have our in-house as well as outside counsel experts explain what small and mid-size pharma and medical device companies need to know how to do when it comes to remaining compliant.

• Government’s relentless focus on Patient Assistance Programs will be explained as well as strategies given as to how to approach them in our session focusing on Building Safeguards into Patient Assistance and Support Programs in order to Mitigate Risk.

• We will look to gain some clarity on Potential Fraud and Abuse Risks Associated with Value-Based Contracting.

• We will concentrate on delineating best practices with respect to monitoring distributors and sub-distributorsas well as on lessons learned from recent FCPA investigations.

• We will examine increased scrutiny of speaker programs, determine appropriate interactions with the healthcare providers, and see how to maintain a proper role of medical affairs personnel.

2018 Speakers

Kenneth M. Abell
Assistant United States Attorney, Chief, Civil Health Care Fraud, United States Attorney’s Office Eastern District of New York

Michele L. Adelman
Vice President & Deputy General Counsel, Fresenius Medical Care North America

Kriss Basil
Assistant United States Attorney, United States Attorney’s Office District of Massachusetts

Linda A. Baumann
Partner, Arent Fox Llp

Thomas Beimers
Partner, Hogan Lovells US Llp

Tracy Palmer Berns
Chief Compliance Officer, AMAG Pharmaceuticals, Inc.

Christopher J. Cestaro
Assistant Chief Criminal Division, Fraud Section FCPA Unit, Department of Justice

Thomas F. Corcoran
Deputy Civil Chief, United States Attorney’s Office District of Maryland

Benjamin M. Daniels
Assistant General Counsel, Fresenius Medical Care North America

Jennifer A. DiFruscio
Commercial Counsel, Legal Affairs, Sunovion Pharmaceuticals Inc.

Jacob T. Elberg
Chief, Health Care & Government Fraud Unit, U.S. Attorney's Office, District of New Jersey

Ann K. Ford
Chief Ethics & Compliance Officer, Medline Industries, Inc.

Hollie K. Foust
Senior Vice President, Ethics & Compliance, Cardinal Health

Anthony E. Fuller
Partner, Hogan Lovells US Llp

Abraham R. George
Assistant United States Attorney, United States Attorney’s Office District of Massachusetts

Kate W. Hardey
Partner, McGuireWoods Llp

Abigail A. Hazlett
Partner, Pepper Hamilton Llp

Christian J. Krautkramer
Senior Compliance Counsel, GE Healthcare

Marc Larkins
Senior Counsel, Johnson & Johnson

Matthew J. Lash
Trial Attorney Consumer Protection Branch, Department of Justice

Veronica M. Lei
Counsel-Litigation and Legal Compliance, Eli Lilly and Company

Peter Leininger
Counsel, King & Spalding Llp

Jennifer H. McGee
Vice President & Chief Compliance Officer, Otsuka America Pharmaceutical, Inc.

Heather K. McShain
Assistant United States Attorney, Deputy Chief and Supervisor of Healthcare Fraud Unit, United States Attorney’s Office, Northern District of Illinois

Rebecca L. Orttel
Senior Legal Director Integrated Health Solutions and Medtronic Foundation, Medtronic Inc.

Jonathan M. Phillips
Attorney, Gibson, Dunn & Crutcher Llp

Carol A. Poindexter
Partner, Norton Rose Fulbright US Llp

Andy Rittenberg
Vice President, Legal, Gilead Sciences

Jennifer Santos
Head of Global Corporate Compliance Operations, Vertex Pharmaceuticals

David S. Schumacher
Partner, Hooper Lundy & Bookman Pc

Eve M. Slattery
Partner, Hogan Lovells US Llp

Ritesh Srivastava
Director, Compliance, Avanir Pharmaceuticals, Inc.

Keren Tenenbaum
Assistant General Counsel, Pfizer Inc.

William Weinreb
Chief of National Security, United States Attorney’s Office, District of Massachusetts

K. Nathaniel Yeager
Assistant United States Attorney, Health Care Fraud Unit Chief, United States Attorney’s Office District of Massachusetts

CO-CHAIRS:

Laura M. Kidd Cordova
Partner, Crowell & Moring

Katherine DeKam
Chief Compliance Officer, Director of Compliance, Acumed

2018 Supporting Sponsor

• Hogan Lovells